Do people with cystic fibrosis experience side effects from Elexacaftor/Tezacaftor/Ivacaftor because of high drug levels?
How people with CF access CFTR modulators in countries where coverage is not provided by health systems
Understanding rates of and factors associated with elexacaftor/tezacaftor/ivacaftor (ETI) prescription
A study on how the newest modulator medication elexacaftor/tezacaftor/ivacaftor affects the gut over time using MRI scans
Evaluating the Effectiveness of a Novel CF Medication for People Without Common Cystic Fibrosis-causing Genetic Mutations
The impact of elexacaftor/tezacaftor/ivacaftor on anxiety and depression in adults with Cystic Fibrosis
